TrialAnnals of clinical and translational neurology2025

Phase 1, First-In-Human, Single-/Multiple-Ascending Dose Study of Iluzanebart in Healthy Volunteers.

Andreas Meier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.